Figma Inc
FIG
$18.97
+1.82%
Figma, Inc. operates a collaborative cloud platform for digital product design and development, bringing design, code, AI agents, and prototyping tools together into a single subscription-based workspace that spans ideation through deployment, with operations across North America, South America, Europe, Australia, and Asia. The company is the category-defining leader in browser-based collaborative design, having displaced incumbents through its multiplayer editing model and now positioning itself as a broader product-development platform rather than a point-solution design tool. The current investor debate centers on whether Figma can convert its roughly 43% year-over-year revenue growth into durable profitability, with bulls pointing to AI product adoption and strong free cash flow generation while bears highlight widening GAAP losses, a post-IPO valuation reset, and intensifying competition from AI-native design tools. Sentiment has been further pressured by the stock's steep post-listing drawdown and a broader de-risking in high-multiple growth software amid rate-hike expectations, leaving the narrative split between a long-term platform-compounder story and a near-term execution-and-margin skepticism.…
FIG
Figma Inc
$18.97
Related headlines
Investment Opinion: Should I buy FIG Today?
Rating: Hold. Figma is a category-leading design platform with genuinely elite unit economics — 42.76% year-over-year revenue growth, an 80.33% Q3 gross margin, $223.5 million of trailing free cash flow, and a net-cash balance sheet (debt-to-equity 0.0757, current ratio 2.58) — but the equity is caught between a de-rated multiple and a still-unproven path to GAAP profitability, so the risk/reward is balanced rather than compelling at $18.81. The analyst consensus of "buy" with a $27.77 average target (+47.6% upside) and a 2.44 recommendation mean (5 Buy, 11 Hold, 0 Sell) frames the setup precisely: the Street likes the business but is waiting for a margin proof point before adding conviction.
Supporting evidence cuts both ways. On the positive side, revenue has compounded sequentially from $333.4 million in Q1 to $370.1 million in Q2 to $391.4 million in Q3, gross profit dollars reached $314.4 million in Q3 against $205.2 million of R&D and $130.7 million of S&M, and the P/S multiple has compressed from 62.87x at year-end 2025 to 18.09x today (EV/sales just 6.05x) even as growth held above 40%, with a PEG of 0.72 and a forward PE of 47.79x on $0.42 of consensus EPS. On the negative side, Q3 net income was -$81.3 million (-20.78% margin) and operating income -$119.2 million (-30.44% margin), the positive FCF is bridged by $158.6 million of quarterly stock-based compensation, gross margin slipped from 83.66% in Q2 to 80.33% in Q3, and the stock is down 59.09% over twelve months versus SPY's +9.59% (relative strength -68.68%), sitting just 7.7% above its $16.60 52-week low.
The biggest risks that could invalidate a constructive view are (1) revenue growth decelerating below 40% while SBC stays elevated, which would break the $0.42 forward EPS estimate and the $27.77 target, (2) further gross-margin erosion from 80.33% as AI inference costs and AI-native competitors pressure pricing, and (3) continued multiple compression given the stock still trades at a 50-100% premium to high-growth application-software peers. This Hold would upgrade to Buy if Q4/Q1 results show operating margin improving toward breakeven with gross margin holding above 80% and revenue growth above 40%, or if the price retests the $16.60 low with stabilizing momentum; it would downgrade to Sell if revenue growth falls below 35% or gross margin drops below 78%. Verdict: fairly valued to modestly undervalued relative to its own post-IPO history (18.09x vs. 62.87x sales), but still at a premium to peers — a show-me story rather than a bargain.
Sign up to view all
FIG 12-Month Price Forecast
Figma presents a classic high-quality-business, unresolved-valuation setup: 42.76% growth and an 80.33% gross margin are elite, but a -30.44% operating margin and $158.6 million of quarterly SBC mean the 47.79x forward PE rests entirely on an unproven swing to profitability. The 71% de-rating in the sales multiple to 18.09x, combined with a 6.05x EV/sales and 0.72 PEG, suggests much of the margin skepticism is priced in, which is why the analyst consensus shows zero Sells and a $27.77 average target implying +47.6% upside. Against that, the stock's -59.09% twelve-month decline, -68.68% relative strength versus SPY, and position just 7.7% above the $16.60 low show the market is still distributing shares and the downtrend is accelerating (-13.00% over one month). I would upgrade to bullish on a confirmed margin inflection — operating margin improving sequentially with gross margin above 80% and growth above 40% — and downgrade to bearish if growth falls below 35% or the $16.60 low breaks decisively.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Figma Inc's 12-month outlook, with a consensus price target around $27.41 and implied upside of +44.5% versus the current price.
Average Target
$27.41
16 analysts
Implied Upside
+44.5%
vs. current price
Analyst Count
16
covering this stock
Price Range
$22 - $34
Analyst target range
Coverage is moderate with 11 analysts, and the distribution is notably cautious for a high-growth name: 5 Buy, 11 Hold, and 0 Sell, yielding a consensus recommendation of "buy" but a recommendation mean of 2.44 that sits closer to Hold than to a strong Buy. The average target price of $27.77 implies roughly +47.6% upside from the current $18.81, a wide gap that reflects how far the stock has fallen below where the Street's models still sit rather than fresh bullish conviction. The consensus is best characterized as neutral-to-constructive — analysts are not capitulating with Sell ratings, but the heavy Hold weighting signals a wait-and-see posture pending evidence of margin inflection.\n\nThe target range of $22.00 to $34.00 is wide relative to the current price, with even the low target implying +16.9% upside and the high target implying +80.8% — a spread that signals meaningful disagreement about the company's earnings power. The high target likely assumes successful AI monetization, operating leverage as SBC normalizes, and multiple re-expansion toward growth-software peers, while the low target prices in persistent GAAP losses, competitive pressure from AI-native design tools, and a continued de-rating. Institutional actions show a stable-to-mixed pattern: Citigroup, Wells Fargo, and B of A maintain Buy/Overweight ratings, while JP Morgan and RBC reiterated Neutral/Sector Perform as recently as November 5, 2026, and Stifel remains at Hold — no recent upgrades or downgrades, suggesting analysts are holding fire until the next earnings print clarifies the margin trajectory. The combination of a 47.6% implied upside to consensus and a 2.44 recommendation mean is a classic setup for a stock where the price has outrun the downgrade cycle but the fundamental proof point has yet to arrive.
Drowning in data?
Find the real signal!
Bulls vs Bears: FIG Investment Factors
The bear case currently has stronger near-term evidence: the stock is in an accelerating downtrend (-13.00% over one month, -19.24% over three months), sits 7.7% above its 52-week low, and the company still burns $81.3 million of GAAP net income per quarter with FCF propped up by $158.6 million of quarterly SBC. The bull case rests on genuinely elite fundamentals — 42.76% revenue growth, 80.33% gross margin, $223.5 million of TTM FCF, and a net-cash balance sheet — that have been de-rated to 18.09x sales from 62.87x a year ago. The single most important tension is whether Figma can convert its 80% gross margin into GAAP operating leverage as SBC normalizes; if the forward EPS of $0.42 materializes, the 47.79x forward PE and 0.72 PEG look reasonable, but if losses persist the 18x sales multiple is still not cheap. Analyst positioning (2.44 mean, 11 Holds, zero Sells) captures this standoff precisely: the Street is not bearish on the business, only unconvinced on the margin timeline.
Bullish
- Revenue compounding above 40%: Q3 2026 revenue of $391.4 million grew 42.76% year-over-year, with sequential expansion from $333.4 million in Q1 to $370.1 million in Q2 to $391.4 million in Q3. Consensus forward revenue of $3.23 billion implies the Street still expects roughly 46% growth, far ahead of the broader application-software sector.
- Best-in-class 80% gross margin: Gross margin of 80.33% in Q3 (and 82.4% on a trailing basis) gives Figma enormous incremental profit potential on every new subscription dollar. R&D of $205.2 million and S&M of $130.7 million are discretionary investments against $314.4 million of quarterly gross profit, not structural cost problems.
- Positive free cash flow, fortress balance sheet: Trailing-twelve-month free cash flow is $223.5 million, with quarterly FCF of $41.5 million in Q3, $54.2 million in Q2, and $88.6 million in Q1. Debt-to-equity of 0.0757, a current ratio of 2.58, and $518.3 million of cash mean the business can self-fund growth with effectively no leverage risk.
- Valuation reset to post-IPO low: The P/S multiple has compressed from 62.87x at year-end 2025 to 18.09x today, a roughly 71% de-rating even as revenue grew more than 40%. EV/sales of just 6.05x and a PEG of 0.72 suggest the market has already priced in substantial margin and competitive skepticism.
Bearish
- GAAP losses remain deep and persistent: Q3 2026 net income was -$81.3 million (-20.78% net margin), operating income was -$119.2 million (-30.44% margin), and EBITDA was -$71.9 million. The sequential improvement from Q1's -$142.4 million loss is real but leaves the company far from GAAP profitability.
- FCF depends on heavy stock-based compensation: The gap between positive $223.5 million TTM free cash flow and negative net income is bridged largely by $158.6 million of SBC in Q3 alone. That is a genuine dilution cost, and the forward PE of 47.79x on $0.42 of consensus EPS depends on SBC normalization that has not yet occurred.
- Falling-knife price action: The stock is down 59.09% over twelve months and 49.99% year-to-date versus SPY's +9.59%, a relative strength of -68.68%. At $18.81 it sits just 7.7% above the $16.60 52-week low and 58.6% below the $45.42 high, with the 1-month decline of -13.00% steeper than the 6-month decline of -8.95% — the downtrend is accelerating.
- Premium multiple versus peers: At 18.09x trailing sales, Figma trades at roughly a 50-100% premium to high-growth application-software peers in the high-single to low-double digits. Price-to-book of 12.64x and price-to-cash-flow of 76.18x confirm investors are capitalizing future cash generation, leaving little room for execution error.
FIG Technical Analysis
Figma is locked in a pronounced downtrend, with the stock down 59.09% over the trailing year and 49.99% year-to-date, a severe underperformance against a SPY that gained 9.59% over the same twelve months (relative strength of -68.68%). At $18.81, the shares sit just 7.7% above the 52-week low of $16.60 and a staggering 58.6% below the 52-week high of $45.42, placing the stock at roughly 7.7% of its 52-week range — deep in the bottom decile and indicative of a falling-knife profile rather than a constructive base. The maximum drawdown of -76.31% underscores how violent the de-rating has been since listing, and with the price hugging the lower boundary of its range, the burden of proof remains on buyers to establish a floor.\n\nShort-term momentum is deteriorating rather than stabilizing: the stock is down 13.00% over the past month and 19.24% over three months, both worse than the 6-month decline of 8.95%, meaning the rate of decline is accelerating into the present. This is a bearish divergence from an already weak long-term trend, and the 1-month relative strength of -8.01 versus SPY confirms Figma is being sold harder than the market during the recent risk-off tape. The most recent session did print a modest bounce of +2.01% off the prior close of $18.44, but a single up-day following a sharp drop to $18.44 on November 5 offers little evidence of capitulation; volume of roughly 12.6 million shares suggests active distribution rather than quiet accumulation.\n\nKey technical levels are well defined: support rests at the $16.60 52-week low, and a decisive breakdown below that level would likely trigger momentum-driven selling and open a fresh leg lower with no historical reference points beneath it. Resistance is layered, with the $22-24 zone (the October consolidation area) as the first hurdle and the $30.62 August spike high as the more meaningful reclaim level; a breakout above $24 would be the first constructive signal of a trend change. Volatility context matters enormously here — with a short ratio of 3.29 and a 76% peak-to-trough drawdown, position sizing should assume high beta-like swings even though a formal beta is not available in the dataset, and any long exposure warrants tight risk controls given the stock's demonstrated capacity for double-digit percentage moves within weeks.
Beta
—
—
Max Drawdown
-76.3%
Largest decline past year
52-Week Range
$17-$45
Price range past year
Annual Return
-57.4%
Cumulative gain past year
| Period | FIG Return | S&P 500 |
|---|---|---|
| 1m | -13.6% | -2.4% |
| 3m | -28.0% | -2.3% |
| 6m | -17.2% | +2.8% |
| 1y | -57.4% | +11.3% |
| ytd | -49.6% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FIG Fundamental Analysis
Figma's top line remains genuinely strong: Q3 2026 revenue of $391.4 million grew 42.76% year-over-year, and the sequential cadence from $333.4 million in Q1 to $370.1 million in Q2 to $391.4 million in Q3 shows consistent absolute expansion of roughly $20-37 million per quarter. Trailing four-quarter revenue sums to approximately $1.40 billion, and consensus estimates for the forward period of $3.23 billion imply the Street expects growth to persist at a robust clip, consistent with the 46% growth narrative highlighted in recent coverage. The growth is broad-based subscription revenue with no segment disclosure provided, but the trajectory implies Figma is still early in enterprise penetration and that AI product adoption is additive rather than cannibalistic to the core design seat model.\n\nProfitability is the weak link: Q3 2026 net income was -$81.3 million on a -20.78% net margin, with operating income of -$119.2 million (-30.44% operating margin) and EBITDA of -$71.9 million. The loss trajectory has actually improved sequentially from Q1's -$142.4 million net loss and -42.71% net margin, but the year-ago Q3 2025 loss of -$1.10 billion was distorted by a massive $1.14 billion stock-based compensation charge tied to IPO-related vesting, so the clean comparison is less flattering. Gross margin remains best-in-class at 80.33% in Q3 (down from 83.66% in Q2 and 79.41% in Q1), and the cost structure is dominated by R&D at $205.2 million and sales and marketing at $130.7 million — investments that are appropriate for a land-and-expand software model but currently swamp the 80%+ gross profit dollars.\n\nThe balance sheet is a genuine strength that offsets the income-statement losses: debt-to-equity is just 0.0757, the current ratio is 2.58, and cash stood at $518.3 million at quarter-end, giving Figma ample liquidity with effectively no leverage risk. Free cash flow is positive and meaningful — $223.5 million on a trailing-twelve-month basis, with quarterly FCF of $41.5 million in Q3, $54.2 million in Q2, and $88.6 million in Q1 — though the gap between positive FCF and negative net income is bridged largely by stock-based compensation of $158.6 million in Q3 alone, a real dilution cost that investors must weigh. ROE of -82.78% and ROA of -15.53% reflect the GAAP losses against a relatively small equity base, but the cash generation profile suggests the business can self-fund growth without external financing, which materially lowers financial risk even as the profitability timeline remains the central uncertainty.
Quarterly Revenue
$391415000.0B
2026-09
Revenue YoY Growth
+42.8%
YoY Comparison
Gross Margin
80.3%
Latest Quarter
Free Cash Flow
$223474000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FIG Overvalued?
Because Figma's trailing net income is negative (-$0.065 EPS, trailing PE of -15.25x), the PE ratio is not a meaningful primary metric, and I have selected the price-to-sales ratio as the lead valuation gauge, supplemented by the forward PE. The stock trades at 18.09x trailing sales and 6.05x EV/sales, while the forward PE of 47.79x against consensus EPS of $0.42 signals that the market expects a dramatic swing to profitability within the next twelve months — the enormous gap between the negative trailing multiple and the positive forward multiple is the single most important valuation fact about this stock. The PEG ratio of 0.72 suggests that, if the forward earnings materialize, the growth-adjusted valuation is not unreasonable despite the optically rich sales multiple.\n\nOn a peer basis, an 18.09x P/S multiple is a premium to the broader application-software sector, where high-growth names typically trade in the high-single to low-double digits, implying a premium of roughly 50-100% depending on the peer set; however, Figma's 42.76% revenue growth and 80.33% gross margin justify a growth-adjusted premium relative to slower-growing peers. The EV/sales of 6.05x is notably lower than the headline P/S of 18.09x, a discrepancy driven by the large cash and investment balance relative to the enterprise value, which flatters the enterprise-level multiple and suggests the market is paying far less for the operating business than the equity multiple implies. The price-to-book of 12.64x and price-to-cash-flow of 76.18x both confirm that investors are capitalizing future cash generation rather than current fundamentals.\n\nHistorical context is striking: Figma's P/S ratio has compressed from 62.87x at year-end 2025 and 33.19x in Q1 2026 to 28.59x in Q3 2026 and 18.09x currently — a roughly 71% de-rating in the sales multiple over four quarters even as revenue grew more than 40%. This places the stock at the very bottom of its own post-IPO valuation band, which cuts both ways: it may represent a genuine value opportunity if growth proves durable, or it may reflect the market's rational reassessment of terminal margins and competitive risk in an AI-disrupted design software market. The compression from 240x P/S in early 2025 to today's 18x is a cautionary reminder that early-stage software multiples can normalize far more than growth-focused investors expect.
PE
-10.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~16985x
vs. Industry Avg
31.1x
Industry PE ~31.1x*
EV/EBITDA
-10.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the persistent GAAP loss profile. Q3 2026 produced a -$81.3 million net loss (-20.78% margin) and -$119.2 million operating loss (-30.44% margin), and the positive $223.5 million TTM free cash flow is bridged by $158.6 million of quarterly stock-based compensation — meaning cash generation overstates economic profitability and dilution is a recurring cost. Gross margin has also slipped from 83.66% in Q2 to 80.33% in Q3, and with R&D at $205.2 million and S&M at $130.7 million, the company must sustain 40%+ growth to ever absorb its cost base. The forward PE of 47.79x on $0.42 of consensus EPS embeds a dramatic swing to profitability within twelve months; any delay in that inflection would leave the valuation without an earnings anchor.
Market and competitive risks are dominated by multiple compression and AI-native disruption. The P/S multiple has already collapsed from 62.87x at year-end 2025 to 18.09x today, and at 18.09x trailing sales Figma still trades at roughly a 50-100% premium to high-growth application-software peers, leaving room for further de-rating if growth decelerates. The stock's relative strength of -68.68% versus SPY over twelve months and -8.01% over the past month shows it is being sold harder than the market during risk-off tapes, consistent with the May 2026 rate-hike panic that hit high-multiple growth software. Competition from AI-native design tools and the risk that AI features cannibalize rather than expand the core seat model remain the central competitive threats, and the 11-of-16 Hold consensus with no recent upgrades means there is no analyst catalyst cushioning a negative surprise.
The worst-case scenario is a chain in which Q4 or Q1 results show revenue growth decelerating below 40%, gross margin slipping further from 80.33%, and SBC remaining elevated — forcing analysts to cut the $0.42 forward EPS estimate and the $27.77 average target while the stock breaks the $16.60 52-week low. With no historical reference points beneath that level and a demonstrated -76.31% maximum drawdown since listing, momentum-driven selling could extend the decline well past the low. From the current $18.81, a move to the $16.60 52-week low is roughly -11.8%, while a retest of the drawdown magnitude or a de-rating toward the $22.00 low target's implied downside would put losses in the -20% to -35% range; the short ratio of 3.29 and 12.6 million-share daily volume suggest active distribution that could accelerate such a move.
FAQ
The most severe risk is the profitability timeline: Q3 2026 produced a -$81.3 million net loss (-20.78% margin) and -$119.2 million operating loss (-30.44% margin), and the positive $223.5 million TTM free cash flow is bridged by $158.6 million of quarterly SBC, so cash generation overstates economic earnings and the 47.79x forward PE has no cushion if the $0.42 EPS slips. Second is multiple compression: at 18.09x sales FIG still trades at a premium to peers, and the May 2026 rate-hike panic showed how quickly high-multiple software de-rates — the stock's -68.68% one-year relative strength versus SPY confirms it is sold hardest in risk-off tapes. Third is competitive disruption from AI-native design tools, compounded by gross margin already slipping from 83.66% in Q2 to 80.33% in Q3 as inference costs and pricing pressure bite. Fourth is company-specific momentum and dilution risk: a -76.31% maximum drawdown, a price 7.7% above the $16.60 low, and a 3.29 short ratio mean a break of support could accelerate selling with no historical floor beneath it.
The twelve-month forecast splits into three scenarios summing to 100%. The base case (50% probability, $22.00-$27.77) assumes growth decelerates modestly but stays above 35%, gross margin holds in the 79-82% band, and the multiple neither re-rates nor de-rates, producing roughly +17% to +48% from $18.81. The bull case (25%, $30.00-$34.00) requires operating margin to narrow toward breakeven, gross margin above 80%, and SBC normalization that validates the $0.42 EPS, driving a retrace toward the $30.62 August spike high and the $34.00 analyst high — roughly +60% to +81%. The bear case (25%, $16.60-$18.00) sees growth below 35%, gross margin under 78%, and a break of the $16.60 low, implying -12% to -20% with tail risk toward the low-$16s. The base case is most likely, hinging on whether the next two quarters show sequential margin improvement without sacrificing 40%+ growth.
The answer depends on the metric, which is precisely the tension in the name. On trailing sales, FIG trades at 18.09x — roughly a 50-100% premium to high-growth application-software peers — but that multiple has already compressed about 71% from 62.87x at year-end 2025 even as revenue grew over 40%, placing the stock at the bottom of its own post-IPO band. Enterprise value tells a friendlier story: EV/sales of just 6.05x reflects the large cash balance ($518.3 million) against enterprise value, and a PEG of 0.72 suggests the growth-adjusted price is not stretched if earnings materialize. The catch is the 47.79x forward PE on $0.42 of consensus EPS, which prices in a dramatic swing from a -$0.065 trailing EPS to profitability within twelve months. The market is therefore paying a fair-to-modestly-undervalued price relative to Figma's own history but a premium to peers, implying it expects durable 40%+ growth and a credible margin inflection.
From a risk/reward standpoint FIG is a balanced, not compelling, proposition at $18.81. The upside case is anchored by a $27.77 average analyst target (+47.6%) and even the $22.00 low target implying +16.9%, backed by 42.76% revenue growth, an 80.33% gross margin, and $223.5 million of trailing free cash flow. The downside is equally concrete: the stock is down 59.09% over twelve months with relative strength of -68.68% versus SPY, sits only 7.7% above its $16.60 52-week low, and still loses $81.3 million per quarter on a GAAP basis with $158.6 million of quarterly SBC. With 11 of 16 ratings at Hold and a 2.44 recommendation mean, the Street itself is waiting for a margin proof point. It is a reasonable buy only for growth investors with a multi-year horizon who can tolerate a retest of the low-$16s, and a poor fit for anyone needing near-term momentum or income.
FIG is structurally a long-term holding and a poor short-term vehicle. It listed only in July 2025, is still in its high-growth investment phase (R&D of $205.2 million and S&M of $130.7 million in Q3 against $314.4 million of gross profit), pays no dividend (payout ratio 0), and has negative trailing EPS of -$0.065, so there is no income or earnings floor to support trading-oriented positions. Volatility is extreme — a -76.31% maximum drawdown, a 59.09% one-year decline, and a 13.00% one-month drop — and with a 3.29 short ratio and 12.6 million-share daily volume, short-term price action is driven by momentum and macro rate sentiment rather than fundamentals. Earnings visibility is limited to a forward EPS estimate of $0.42 that has not yet been proven. A minimum holding period of 18-24 months is appropriate, giving the company several quarters to demonstrate operating leverage and SBC normalization before the thesis can be judged.